Characteristic;"Frequency (%)"
"<1 year";"29 (17.1)"
"1–5 year";"138 (81.2)"
">5 year";"3 (1.8)"
"Duration of Sac/Val use in years (Mean ± (SD))";"2.1 ± (1.5)"
"Initiation pattern of Sac/Val"
"De novo";"106 (62.4%)"
"Previous use of ACEIs";"36 (21.1%)"
"Previous use of ARBs";"35 (20.6%)"
"Starting dose of Sac/Val"
"50 mg BD";"134 (78.8)"
"100 mg BD";"27 (15.9)"
"200 mg BD";"9 (5.3)"
"Dose titration"
Titrated;"122 (71.8)"
"Not titrated";"48 (28.2)"
"Max. dose received"
"50 mg (BD)";"35 (20.6)"
"100 mg (BD)";"73 (42.9)"
"200 mg (BD)";"62 (36.5)"
"Availability of Sac/Val"
"Always available";"77 (45.3)"
"Sometimes available";"93 (54.7)"
"Cost of Sac/Val"
Suitable;"2 (1.2)"
Expensive;"36 (21.2)"
"Very expensive";"132 (77.6)"
"Insurance coverage"
Yes;"13 (7.6)"
No;"157 (92.4)"